Advent Capital Management BRIDGEBIO PHARMA INC Transaction History

Advent Capital Management

16,798,000

Previous 2,688,000 524.93%

Previous $0 NaN%

0.0%

Previous 0.0%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	N/A	14,110,000 Added 524.93%	16,798,000 $0
Q4 2024 Feb 13, 2025	SELL	N/A	-16,256,000 Reduced 85.81%	2,688,000 $0
Q3 2024 Nov 13, 2024	SELL	N/A	-4,249,000 Reduced 18.32%	18,944,000 $0
Q2 2024 Aug 13, 2024	SELL	N/A	-16,856,000 Reduced 42.09%	23,193,000 $0
Q1 2024 May 14, 2024	BUY	N/A	4,334,000 Added 12.13%	40,049,000 $0
Q4 2023 Feb 13, 2024	BUY	N/A	6,227,000 Added 21.12%	35,715,000 $0
Q3 2023 Nov 13, 2023	BUY	N/A	27,688,000 Added 1538.22%	29,488,000 $0
Q1 2023 May 12, 2023	BUY	N/A	1,800,000 New	1,800,000 $0

Get notified when there are updates to the investment portfolio of Advent Capital Management , based on Form 13F filings with the SEC.

Stay updated on Advent Capital Management with notifications on news.